Davos Alzheimer's Collaborative Healthcare System Preparedness to Increase Cognitive Assessment Rates for Older Adults

Last updated: January 9, 2024
Sponsor: Ludwig-Maximilians - University of Munich
Overall Status: Active - Recruiting

Phase

N/A

Condition

Memory Loss

Mild Cognitive Impairment

Memory Problems

Treatment

ki:elements digital speech biomarker for cognition (ki:e SB-C)

Subjective cognitive decline questionnaire (SCD-Q)

Cognigram

Clinical Study ID

NCT06191952
22-0786
  • Ages > 65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

In this study the investigators explore a pragmatic strategy to increase cognitive screening rates in the community. The investigators will compare the monetary value of different combinations of SCD questionnaires, digital cognitive tests, and blood Alzheimer's Disease (AD) biomarkers to identify the best approach for primary care settings.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • age 65 years or older

Exclusion

Exclusion Criteria:

  • younger than 65 years

Study Design

Total Participants: 500
Treatment Group(s): 4
Primary Treatment: ki:elements digital speech biomarker for cognition (ki:e SB-C)
Phase:
Study Start date:
February 01, 2023
Estimated Completion Date:
February 01, 2024

Study Description

The investigators aim to perform a cluster-randomized study, exploring the effectiveness, efficiency, and acceptability of a pragmatic strategy to increase cognitive screening rates in the community. Participants will be older adults attending social and cultural centers in the greater Munich area. The investigators will compare the monetary value of different combinations of SCD questionnaires, digital cognitive tests, and blood AD biomarkers to identify the best approach for primary care settings. As secondary aims, qualitative interviews will be conducted with general practitioners (GPs) and their patients to explore the acceptability of the proposed new screening strategy; furthermore, the diagnostic utility of an artificial intelligence-based automated analysis of speech will be assessed. The initiative will not only generate novel insights into the optimal approach for large-scale cognitive screening in the general population, but also contribute to an urgently required cultural change in Germany, resulting in a sustainable solution for effective and efficient early recognition and prevention of dementia.

Connect with a study center

  • Klinik und Poliklinik für Psychiatrie und Psychotherapie des LMU Klinikums

    München, Bayern 80336
    Germany

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.